FDA to Reopen Comment Period for BHT Request for Information

July 10, 2026

FDA has announced that it will reopen the comment period for the Request for Information (RFI) on butylated hydroxytoluene (BHT) in human food and as a food contact substance (Docket No. FDA-2026-N-2526) for 30 days.

The new deadline for submitting comments, data, and scientific information will be announced when the reopening notice is published in the Federal Register. FDA will reopen the comment period in response to stakeholder requests for additional time to compile and submit relevant data and scientific information.

Electronic comments may be submitted through Regulations.gov using docket number FDA-2026-N-2526. Written comments should be submitted to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852, and should identify docket number FDA-2026-N-2526.

Please note that FDA is not reopening the comment period for the Request for Information on azodicarbonamide (Docket No. FDA-2026-N-4126), as the agency did not receive stakeholder requests for additional time.

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.

R.G. Client

I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.

Mike H. Client

Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.

Dr. Sastry Client

I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.

Claire P. Client